Rifabutin

Revision as of 02:14, 31 December 2013 by Chetan Lokhande (talk | contribs) (→‎FDA Package Insert)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Rifabutin
MYCOBUTIN^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Overview

Category

US Brand Names

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages

Mechanisms of Action

References

Retrieved from "https://www.wikidoc.org/index.php?title=Rifabutin&oldid=921676"

Cookies help us deliver our services. By using our services, you agree to our use of cookies.